CoChat

Metformin and insulin treatment prevent placental telomere attrition in boys exposed to maternal diabetes

Open access

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Shortened leukocyte and placental telomeres associated with gestational diabetes mellitus (GDM) suggest this exposure triggers telomere attrition contributing to adverse outcomes. We applied high resolution Single Telomere Length Analysis (STELA) to placenta from GDM pregnancies with different treatment pathways to determine their effectiveness at preventing telomere attrition. Differences in telomere length between control (N = 69), GDM lifestyle intervention (n = 14) and GDM treated with metformin and/or insulin (n = 17) was tested by Analysis of Covariance (ANCOVA) followed by group comparisons using Fisher's least significant difference. For male placenta only, there were differences in mean telomere length (F(2,54) = 4.98, P = 0.01) and percentage of telomeres under 5 kb (F(2,54) = 4.65, P = 0.01). Telomeres were shorter in the GDM lifestyle intervention group compared to both controls (P = 0.02) and medically treated pregnancies (P = 0.003). There were more telomeres under 5 kb in the GDM lifestyle intervention group compared to the other two groups (P = 0.03 and P = 0.004). Although further work is necessary, we suggest that early adoption of targeted medical treatment of GDM pregnancies where the fetus is known to be male may be an effective strategy for ameliorating adverse outcomes for children.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0208533

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Representative STELA comparing placental samples from control, GDM lifestyle intervention (labelled GDM) and GDM medication (labelled GDM+M) groups. Red dashed line across the STELA profiles indicate the mean. Each sample is analysed with six STELA reactions. Mean telomere lengths are presented below each sample (±SD).
Fig 1 Representative STELA comparing placental samples from control, GDM lifestyle intervention (labelled GDM) and GDM medication (labelled GDM+M) groups. Red dashed line across the STELA profiles indicate the mean. Each sample is analysed with six STELA reactions. Mean telomere lengths are presented below each sample (±SD).CC BY · PubMed Central
Fig 2 Telomere length differences in placenta from control, GDM and GDM+M groups. Comparison of mean telomere length between control, GDM and GDM+M groups (N = 69+14+17) (a), in male placenta (N = 38+10+10) (c), and in female placenta (N = 31+4+7) (e). Differences in percentage of telomeres under 5kb between control, GDM and GDM+M groups (N = 69+14+17) (b), in male placenta (N = 38+10+10) (d), and in female placenta (N = 31+4+7) (f). Mean telomere length and percentage under 5kb is presented (±SD). ANCOVA test was used to assess statistical significant differences *p<0.05.
Fig 2 Telomere length differences in placenta from control, GDM and GDM+M groups. Comparison of mean telomere length between control, GDM and GDM+M groups (N = 69+14+17) (a), in male placenta (N = 38+10+10) (c), and in female placenta (N = 31+4+7) (e). Differences in percentage of telomeres under 5kb between control, GDM and GDM+M groups (N = 69+14+17) (b), in male placenta (N = 38+10+10) (d), and in female placenta (N = 31+4+7) (f). Mean telomere length and percentage under 5kb is presented (±SD). ANCOVA test was used to assess statistical significant differences *p<0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 25

Metadata

Authors
Garcia-Martin, I., Penketh, R. J. A., Janssen, A. B., Jones, R. E., Grimstead, J., Baird, D. M., & John, R. M.
Affiliations
  • University Hospital of Wales (GB)
  • Cardiff University (GB)
Corresponding author
John, Rosalind M.
Venue
PLOS ONE
Published
2018-12-11
Volume
13
Issue
12
Pages
e0208533
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2901584188
Cited by
24
References
43
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 6 · 2021: 3 · 2020: 2 · 2019: 3
FWCI
2.19
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Medical Research Council (MR/M013960)
  • Biotechnology and Biological Sciences Research Council (BB/F016557)
  • Cancer Research UK (C17199/A18246)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
gestational diabetes mellitus, telomere shortening, metformin, insulin therapy, lifestyle intervention, fetal sex, maternal diabetes
MeSH terms
Adult, Analysis of Variance, Female, Humans, Hypoglycemic Agents, Insulin, Male, Metformin, Placenta, Pregnancy, Case-Control Studies, Telomere, Diabetes, Gestational, Risk Reduction Behavior, Telomere Shortening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin and insulin treatment prevent placental telomere attrition in boys exposed to maternal diabetes. https://app.cochat.ai/papers/10.1371/journal.pone.0208533
The paper
Garcia-Martin, I., Penketh, R. J. A., Janssen, A. B., Jones, R. E., Grimstead, J., Baird, D. M., & John, R. M. (2018). Metformin and insulin treatment prevent placental telomere attrition in boys exposed to maternal diabetes. PLOS ONE. https://doi.org/10.1371/journal.pone.0208533

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.